Nuveen’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $65.8M | Sell |
358,838
-16,719
| -4% | -$3.08M | 0.02% | 532 |
|
|
2025
Q4 | $66.1M | Buy |
375,557
+43,100
| +13% | +$7.04M | 0.02% | 527 |
|
|
2025
Q3 | $46.6M | Sell |
332,457
-9,202
| -3% | -$1.24M | 0.01% | 645 |
|
|
2025
Q2 | $42.9M | Buy |
341,659
+195,228
| +133% | +$24.3M | 0.01% | 674 |
|
|
2025
Q1 | $12.5M | Sell |
146,431
-154,310
| -51% | -$22.1M | ﹤0.01% | 1419 |
|
|
2024
Q4 | $46M | Sell |
300,741
-22,446
| -7% | -$3.79M | 0.01% | 688 |
|
|
2024
Q3 | $62.6M | Buy |
323,187
+1,879
| +0.6% | +$393K | 0.02% | 557 |
|
|
2024
Q2 | $74.5M | Sell |
321,308
-25,808
| -7% | -$5.61M | 0.02% | 488 |
|
|
2024
Q1 | $74.8M | Sell |
347,116
-100,034
| -22% | -$23.4M | 0.02% | 498 |
|
|
2023
Q4 | $116M | Sell |
447,150
-135,603
| -23% | -$33.3M | 0.04% | 363 |
|
|
2023
Q3 | $150M | Sell |
582,753
-23,851
| -4% | -$6.38M | 0.05% | 281 |
|
|
2023
Q2 | $173M | Sell |
606,604
-356
| -0.1% | -$106K | 0.06% | 264 |
|
|
2023
Q1 | $169M | Buy |
606,960
+54,975
| +10% | +$15.2M | 0.06% | 258 |
|
|
2022
Q4 | $153M | Sell |
551,985
-20,703
| -4% | -$5.85M | 0.06% | 287 |
|
|
2022
Q3 | $153M | Buy |
572,688
+66,300
| +13% | +$14.1M | 0.06% | 281 |
|
|
2022
Q2 | $103M | Sell |
506,388
-17,122
| -3% | -$3.5M | 0.04% | 369 |
|
|
2022
Q1 | $108M | Sell |
523,510
-45,656
| -8% | -$9.93M | 0.04% | 403 |
|
|
2021
Q4 | $137M | Sell |
569,166
-1,438
| -0.3% | -$370K | 0.04% | 365 |
|
|
2021
Q3 | $161M | Sell |
570,604
-279,302
| -33% | -$91.5M | 0.05% | 319 |
|
|
2021
Q2 | $294M | Buy |
849,906
+22,598
| +3% | +$6.85M | 0.09% | 215 |
|
|
2021
Q1 | $231M | Sell |
827,308
-76,002
| -8% | -$20.5M | 0.07% | 246 |
|
|
2020
Q4 | $221M | Buy |
903,310
+267,114
| +42% | +$68.9M | 0.07% | 231 |
|
|
2020
Q3 | $180M | Sell |
636,196
-230,187
| -27% | -$64.2M | 0.07% | 247 |
|
|
2020
Q2 | $232M | Sell |
866,383
-145,063
| -14% | -$43.6M | 0.09% | 201 |
|
|
2020
Q1 | $320M | Sell |
1,011,446
-240,244
| -19% | -$72.9M | 0.16% | 133 |
|
|
2019
Q4 | $371M | Buy |
1,251,690
+43,275
| +4% | +$12M | 0.14% | 143 |
|
|
2019
Q3 | $281M | Sell |
1,208,415
-110,665
| -8% | -$25.8M | 0.11% | 176 |
|
|
2019
Q2 | $308M | Buy |
1,319,080
+1,101,563
| +506% | +$254M | 0.12% | 167 |
|
|
2019
Q1 | $51.4M | Buy |
217,517
+80,994
| +59% | +$25.5M | 0.27% | 69 |
|
|
2018
Q4 | $41.1M | Buy |
136,523
+61,473
| +82% | +$19.6M | 0.26% | 80 |
|
|
2018
Q3 | $26.5M | Buy |
75,050
+9,580
| +15% | +$3.3M | 0.14% | 231 |
|
|
2018
Q2 | $19M | Sell |
65,470
-82,338
| -56% | -$23.1M | 0.12% | 266 |
|
|
2018
Q1 | $40.5M | Sell |
147,808
-7,813
| -5% | -$2.43M | 0.26% | 96 |
|
|
2017
Q4 | $49.6M | Buy |
155,621
+19,239
| +14% | +$6.17M | 0.32% | 71 |
|
|
2017
Q3 | $42.7M | Buy |
136,382
+32,989
| +32% | +$9.77M | 0.28% | 88 |
|
|
2017
Q2 | $28.1M | Sell |
103,393
-24,264
| -19% | -$6.42M | 0.18% | 143 |
|
|
2017
Q1 | $34.9M | Sell |
127,657
-18,327
| -13% | -$5.18M | 0.21% | 116 |
|
|
2016
Q4 | $41.4M | Buy |
145,984
+35,560
| +32% | +$10.5M | 0.21% | 111 |
|
|
2016
Q3 | $34.6M | Buy |
110,424
+81,222
| +278% | +$24.1M | 0.2% | 113 |
|
|
2016
Q2 | $7.06M | Sell |
29,202
-72,583
| -71% | -$19.1M | 0.04% | 433 |
|
|
2016
Q1 | $26.5K | Buy |
101,785
+51,375
| +102% | +$13.6M | 0.14% | 154 |
|
|
2015
Q4 | $15.4K | Buy |
50,410
+12,618
| +33% | +$3.63M | 0.08% | 259 |
|
|
2015
Q3 | $11K | Sell |
37,792
-9,844
| -21% | -$3.25M | 0.06% | 311 |
|
|
2015
Q2 | $19.2K | Sell |
47,636
-4,222
| -8% | -$1.69M | 0.1% | 258 |
|
|
2015
Q1 | $21.9M | Sell |
51,858
-18,118
| -26% | -$7.14M | 0.12% | 241 |
|
|
2014
Q4 | $23.8M | Sell |
69,976
-3,868
| -5% | -$1.25M | 0.13% | 211 |
|
|
2014
Q3 | $24.4M | Buy |
73,844
+9,394
| +15% | +$3.1M | 0.15% | 180 |
|
|
2014
Q2 | $20.3M | Sell |
64,450
-2,803
| -4% | -$844K | 0.12% | 225 |
|
|
2014
Q1 | $20.6M | Sell |
67,253
-1,043
| -2% | -$331K | 0.12% | 226 |
|
|
2013
Q4 | $19.1M | Buy |
68,296
+8,635
| +14% | +$2.23M | 0.12% | 240 |
|
|
2013
Q3 | $14.4M | Sell |
59,661
-2,473
| -4% | -$553K | 0.09% | 286 |
|
|
2013
Q2 | $13.4M | Buy |
+62,134
| New | +$13.3M | 0.09% | 291 |
|
Other funds holding BIIB
VCM
VPM
Nuveen's BIIB Position: Q1 2026 in Review
Nuveen reduced its Biogen (BIIB) stake by 4.5% in Q1 2026, selling an estimated $3.08M and leaving 358,838 shares worth $65.8M. The position accounts for 0.02% of the portfolio, ranked #532.
Nuveen first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $371M in Q4 2019. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Nuveen held 358,838 shares of Biogen worth $65.8M as of Q1 2026.
- Nuveen sold 16,719 Biogen shares in Q1 2026, an estimated $3.08M.
- Biogen made up 0.02% of Nuveen's portfolio in Q1 2026, its #532 holding.
- Nuveen first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- Nuveen's Biogen position peaked at $371M in Q4 2019.
- 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.